Leitat Technological Center has patented 1H-pyrazole derivatives acting as sigma nonopioid intracellular receptor 1 (SIGMAR1) and/or sigma intracellular receptor 2 (TMEM97) ligands reported to be useful for the treatment of pain and neurological disorders.